Foghorn Therapeutics

FHTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$356.394 M

$6.07 +8.98%

Close of 7 Aug 2026

Revenue

$30.9M

#2887 by revenue

Earnings

-$74.3M

Loss-making

Shares outstanding

59,385,315

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#227DiaMedica TherapeuticsDMAC$363.7M
#228Lyell ImmunopharmaLYEL$360.5M
#229Foghorn TherapeuticsFHTX$356.4M
#230Galectin TherapeuticsGALT$347.9M
#231Perspective TherapeuticsCATX$342.1M

Where these numbers come from

Share counts and financials for Foghorn Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.